These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25373419)
1. Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012. Mao B; Chheng K; Wannemuehler K; Vynnycky E; Buth S; Soeung SC; Reef S; Weldon W; Quick L; Gregory CJ Epidemiol Infect; 2015 Jul; 143(9):1858-67. PubMed ID: 25373419 [TBL] [Abstract][Full Text] [Related]
2. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling. Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317 [TBL] [Abstract][Full Text] [Related]
3. [Monitoring of implementation of international programs of poliomyelitis eradication and measles and rubella elimination in the Republic of Belarus]. Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):21-30. PubMed ID: 22442967 [TBL] [Abstract][Full Text] [Related]
4. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022. Shanmugasundaram D; Viswanathan R; Winter AK; Agarwal A; Roychowdhury B; Muliyil D; Prasad GRV; Pushpalatha K; Gowda M; Singh P; Priyasree J; Bonu R; Jha S; Kumar Jena S; Jain S; Suri V; Hebbale V; Jain A; Mary Abraham A; Mishra B; Kumar Pati B; Biswas D; Pratkeye D; Ashok M; Singh MP; Dhodapkar R; Ray R; Gadepalli R; Ratho RK; Rani S; Shukla S; Ali A S; Lakshmi Nag V; Sabarinathan R; Saravana Kumar V; Priya R P; Dwibedi B; Sapkal G; Singh H; Singh K; Tiwari L; Jain M; Mondal N; Sreenivasan P; Mahantesh S; Verma S; Awasthi S; Malik S; Santhanam S; Datta S; Kumar A; Kant Chowdhary B; Khera D; Jain M; Kumar P; Pati S; Tripathi S; Murhekar M Vaccine; 2024 Oct; 42(24):126077. PubMed ID: 38960788 [TBL] [Abstract][Full Text] [Related]
5. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey. Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529 [TBL] [Abstract][Full Text] [Related]
6. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy. Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India. Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Mossong J; Putz L; Schneider F Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584 [TBL] [Abstract][Full Text] [Related]
10. Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey. Wanlapakorn N; Wasitthankasem R; Vichaiwattana P; Auphimai C; Yoocharoen P; Vongpunsawad S; Poovorawan Y PLoS One; 2019; 14(11):e0225606. PubMed ID: 31770412 [TBL] [Abstract][Full Text] [Related]
11. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy. Alleman MM; Wannemuehler KA; Hao L; Perelygina L; Icenogle JP; Vynnycky E; Fwamba F; Edidi S; Mulumba A; Sidibe K; Reef SE Vaccine; 2016 Dec; 34(51):6502-6511. PubMed ID: 27866768 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India. Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764 [TBL] [Abstract][Full Text] [Related]
13. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916 [TBL] [Abstract][Full Text] [Related]
14. Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019-20. Shanmugasundaram D; Awasthi S; Dwibedi B; Geetha S; Jain M; Malik S; Patel B; Singh H; Tripathi S; Viswanathan R; Agarwal A; Bonu R; Jain S; Jena SK; Priyasree J; Pushpalatha K; Ali S; Biswas D; Jain A; Narang R; Madhuri S; George S; Kaduskar O; Kiruthika G; Sabarinathan R; Sapakal G; Gupta N; Murhekar MV PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009608. PubMed ID: 34297716 [TBL] [Abstract][Full Text] [Related]
15. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination. Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717 [TBL] [Abstract][Full Text] [Related]
16. Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia. Gao Z; Wood JG; Burgess MA; Menzies RI; McIntyre PB; MacIntyre CR Vaccine; 2013 Jan; 31(4):691-7. PubMed ID: 23196206 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine. Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472 [TBL] [Abstract][Full Text] [Related]
19. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013. Plans P; de Ory F; Campins M; Álvarez E; Payà T; Guisasola E; Compte C; Vellbé K; Sánchez C; Lozano MJ; Aran I; Bonmatí A; Carreras R; Jané M; Cabero L Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1161-71. PubMed ID: 25666082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]